So how do you get more people interested in immunology careers? That is a question of interest to UAB faculty leading the Undergraduate Immunology Program, the only dedicated undergraduate immunology ...
We don't expect to make any significant changes to our $255 fair value estimate for Amgen as a result of the firm's proposed acquisition of Horizon Therapeutics for $28 billion, or $116.50 per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback